Technology | August 16, 2007

Mindray Receives FDA Approval for Hypervisor VI

Mindray received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Hypervisor VI, a central monitoring system.
The BC-3200 three-part differential hematology analyzer is the first automatic diagnostic laboratory instrument introduced by Mindray targeting the North American market.
It is designed to provide reliable, efficient and safe closed-tube sampling with a throughput rate of up to 60 samples per hour. The device is specifically targeted for cost-sensitive healthcare facilities and small laboratories as it delivers both more accurate test results and better overall performance than comparably priced devices.